Adicet Bio Inc - Asset Resilience Ratio

Latest as of September 2025: 52.68%

Adicet Bio Inc (ACET) has an Asset Resilience Ratio of 52.68% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read debt load of Adicet Bio Inc for a breakdown of total debt and financial obligations.

Liquid Assets

$74.00 Million

Cash + Short-term Investments

Total Assets

$140.48 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2008–2024)

This chart shows how Adicet Bio Inc's Asset Resilience Ratio has changed over time. See Adicet Bio Inc (ACET) net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Adicet Bio Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Adicet Bio Inc (ACET) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$74.00 Million	52.68%
Total Liquid Assets	$74.00 Million	52.68%

Asset Resilience Insights

Very High Liquidity: Adicet Bio Inc maintains exceptional liquid asset reserves at 52.68% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Adicet Bio Inc Industry Peers by Asset Resilience Ratio

Compare Adicet Bio Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Fortress Biotech Inc NASDAQ:FBIO	Biotechnology	11.59%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	0.00%
Tubize-Fin BR:TUB	Biotechnology	0.05%
Apellis Pharmaceuticals Inc NASDAQ:APLS	Biotechnology	0.58%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
BrightGene Bio Medical Technology C SHG:688166	Biotechnology	1.00%
BioArctic AB (publ) ST:BIOA-B	Biotechnology	72.35%
Chengzhi Shareholding Co Ltd SHE:000990	Biotechnology	6.73%

Annual Asset Resilience Ratio for Adicet Bio Inc (2008–2024)

The table below shows the annual Asset Resilience Ratio data for Adicet Bio Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	54.40%	$119.81 Million	$220.22 Million	--
2023-12-31	0.00%	$0.00	$207.29 Million	--
2021-12-31	0.00%	$0.00	$338.94 Million	--
2020-12-31	6.69%	$10.28 Million	$153.84 Million	-56.80pp
2019-12-31	63.48%	$51.79 Million	$81.59 Million	-28.37pp
2018-12-31	91.86%	$100.99 Million	$109.94 Million	+88.15pp
2017-12-31	3.71%	$2.05 Million	$55.19 Million	+3.54pp
2016-12-31	0.16%	$881.00K	$540.78 Million	-0.53pp
2015-12-31	0.70%	$3.42 Million	$489.77 Million	+0.54pp
2014-12-31	0.16%	$746.00K	$467.98 Million	-0.50pp
2013-12-31	0.66%	$2.14 Million	$323.43 Million	+0.16pp
2012-12-31	0.51%	$1.52 Million	$299.28 Million	+0.19pp
2011-12-31	0.32%	$943.00K	$294.99 Million	+0.16pp
2010-12-31	0.15%	$335.00K	$216.56 Million	-0.13pp
2009-12-31	0.29%	$541.00K	$189.27 Million	+0.02pp
2008-12-31	0.27%	$548.00K	$205.50 Million	--

pp = percentage points

About Adicet Bio Inc

NASDAQ:ACET USA Biotechnology

Market Cap

$78.72 Million

Market Cap Rank

#20605 Global

#4434 in USA

Share Price

$8.20

Change (1 day)

+8.61%

52-Week Range

$0.47 - $8.82

All Time High

$145.95